Compass Therapeutics, Inc. (NASDAQ:CMPX) is one of the Best Small-Cap Growth Stocks to Invest In Now. Recently, on June 4, Citizens reiterated a Market Outperform rating on the stock with a price ...
Detailed price information for Compass Therapeutics Inc (CMPX-Q) from The Globe and Mail including charting and trades.
Compass Therapeutics, Inc. (CMPX) has been on a downward spiral lately with significant selling pressure. After declining 28.6% over the past four weeks, the stock looks well positioned for a trend ...
Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Is Compass Therapeutics, Inc. (CMPX) one of those stocks right now? By taking a look ...
We recently compiled a list of the 10 Hottest Smid-Cap Stocks So Far In 2025. In this article, we are going to take a look at where Compass Therapeutics, Inc. (NASDAQ:CMPX) stands against the other ...
Detailed price information for Compass Therapeutics Inc (CMPX-Q) from The Globe and Mail including charting and trades.
Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the "long context," investors will essentially be "buying high, but hoping to sell ...
Develops clinical-stage antibody-based therapeutics, including CTX-009, CTX-471, and CTX-8371, targeting cancer and tumor vascularization. Operates as a biotechnology company focused on advancing ...
Compass Therapeutics, Inc. (NASDAQ:CMPX) announced statistically significant topline data on Tuesday on the primary efficacy endpoint for COMPANION-002, the company’s ongoing Phase 2/3 trial of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results